(Circulation. 1999;100:e64.)
© 1999 American Heart Association, Inc.
Circulation Electronic Pages |
Assistant Professor of Medicine Harvard Medical School, Director, Laboratory for Cardiovascular Research, HRCA Research and Training Institute, Boston, Mass
Shuman Cardiovascular Research Fellow HRCA Research and Training Institute, Boston, Mass
| Introduction |
|---|
Recently, Montano et al1 claimed a central vagotonic effect of high-dose atropine was evidenced in peroneal nerve muscle sympathetic outflow (MSNA). However, the authors' conclusions critically depend on "normalized units" to quantify low-frequency (LF) and high-frequency (HF) oscillations, a practice that can impart significance to the fluctuations beyond the regulatory mechanisms they subserve. This led to the conclusion that insight into parasympathetic nervous outflow can be gleaned from activity in a sympathetic nerve. We take issue with the interpretation of these data and believe that despite cautionary argument,2 this approach subsumes the physiological meaning of cardiovascular oscillations to their spectral measures.
Heart period oscillations primarily derive from
beat-by-beat autonomic control of systemic
hemodynamics, ultimately buffering or augmenting
arterial pressure fluctuations.3 Vascular
sympathetic rhythms have been identified also, although they may or may
not be related directly to pressure fluctuations.4 5
Spectral analysis conveniently quantifies these rhythms but in
itself does not reveal their source. The findings of Montano et al rely
solely on "normalizing" power spectral data, a technique that
uncouples the oscillations from their
physiological significance by measuring LF and HF
relative to each other and making absolute amplitude irrelevant. In the
present study, average heart period variance after atropine was
<1% of control, representing almost complete elimination
of beat-by-beat cardiac autonomic regulation. However, normalized units
indicated that high-dose atropine reduced HF variability by only two
thirds and increased LF variability by one third, divorcing spectral
measures from the oscillations' minimal
physiological significance. It is unclear how
Centro L.I.T.A. di Vialba, Centro Ricerche Cardiovascolari, CNR, Medicina Interna II, Ospedale L. Sacco, Università di Milano, Milano, Italy
Cardiovascular Division, Department of Internal Medicine, College of Medicine, University of Iowa, Iowa City, Iowa
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |